Nipple Stimulation for Labor Induction

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05759364` - The Effect of IV PAPAVERINE 80 mg Prior to Catheter Balloon Insertion on Bishop Score and Pain	N/A
Recruiting	`NCT04685668` - The PartoMa Project: Enabling Best Post Possible Childbirth Care in Tanzania.	N/A
Completed	`NCT04200599` - Early Versus Delayed Oxytocin Infusion Following Amniotomy in Nulliparous Women	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT05759364 - The Effect of IV PAPAVERINE 80 mg Prior to Catheter Balloon Insertion on Bishop Score and Pain

N/A

Recruiting

NCT04685668 - The PartoMa Project: Enabling Best Post Possible Childbirth Care in Tanzania.

N/A

Completed

NCT04200599 - Early Versus Delayed Oxytocin Infusion Following Amniotomy in Nulliparous Women

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03025503
Study type	Interventional
Source	Hadassah Medical Organization
Contact	Drorith Hochner-Celnikier, MD
Phone	00 972 2 5844400
Email	hochner@hadassah.org.il
Status	Not yet recruiting
Phase	N/A
Start date	January 2017
Completion date	January 2019

Nipple Stimulation for Labor Induction

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms